Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

SUMOylation in Viral Replication and Antiviral Defense

Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection

SUMOylation: A Link to Future Therapeutics.

Sumoylation at the Host-Pathogen Interface

Role of SUMOylation in Human Oncogenic Herpesvirus Infection

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

The crosstalk between SUMOylation and immune system in host-pathogen interactions

Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus

[Sumoylation and Its Role in Hematological Disease].

SUMOylation Is Essential for Dengue Virus Replication and Transmission in the Mosquito Aedes aegypti

Signalling mechanisms and cellular functions of SUMO

SUMO1 Modification Facilitates Avibirnavirus Replication by Stabilizing Polymerase VP1

Regulation of SARS-CoV-2 Infection and Antiviral Innate Immunity by Ubiquitination and Ubiquitin-Like Conjugation

Protein modification by SUMO.

Analysis of the SUMO2 Proteome during HSV-1 Infection

Sumoylation of the Carboxy-Terminal of Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Attenuates Viral DNA Replication

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response

Protein SUMOylation and disease

Small-Molecule Inhibitors Targeting Protein SUMOylation As Novel Anticancer Compounds.

Post-translational regulation of antiviral innate signaling